期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 424, 期 2, 页码 107-113出版社
ELSEVIER
DOI: 10.1016/S0014-2999(01)01013-5
关键词
anticonvulsant; glutamate receptor, metabotropic; mGlu(4) receptor; mGlu(8) receptor; ACPT-1 ((1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid); PPG (RS)-4-phosphonophenyl-glycine); MSOP (RS)-alpha-methylserine-O-phosphate); DBA/2 mouse; GEP (genetically epilepsy-prone) rat
The metabotropic Group III agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid (ACPT-1), selective for the mGlu(4 alpha) receptor, suppresses sound-induced seizures in DBA/2 mice following its intracerebroventricular (i.c.v.) administration (ED50 5.6 [2.9-10.7], nmol i.c.v., 15 min, clonic phase) and in genetically epilepsy-prone (GEP) rats following focal administration into the inferior colliculus (ED50 0.08 [0.01-0.50], nmol, 60 min, clonic phase). ACPT-1 also protects against clonic seizures induced in DBA/2 mice by the Group I agonist, (RS)-3,5-dihydroxyphenylglycine (3,5-DHPG) (ED50 0.60 [0.29-1.2], nmol i.c.v.) and by the Group III antagonist, (RS)-alpha -methylserine-O-phosphate (MSOP) (ED50 49.3 [37.9-64.1], nmol i.c.v.). Another Group IH agonist, (RS)-4-phosphonophenylglycine (PPG), preferentially activating the mGlu(8) receptor, previously shown to protect against sound-induced seizures in DBA/2 mice and GEP rats, also protects against seizures induced in DBA/2 by 3,5-DHPG (ED50 3.7 [2.4-5.7], nmol i.c.v.) and by the Group III antagonist, MSOP (ED50 40.2 [21.0-77.0], nmol i.c.v.). At very high doses (500 nmol i.c.v. and above), Group III antagonists have pro-convulsant and convulsant activity. The anticonvulsant protection against sound-induced seizures in DBA/2 mice provided by a fully protective dose (20 nmol, i.c.v.) of the mGlu(4) receptor agonist ACPT-1, is partially reversed by the co-administration of the Group III antagonists, MSOP, (RS)-alpha -methyl-4-phosphonophenylglycine (MPPG) or (S)-2-amino-2-methyl-4-phosphonobutanoic acid (MAP4), in the 20-50 nmol dose range. At doses of 50-200 nmol, MPPG and MAP4 cause further reversal of the ACPT-1 anticonvulsant protection, while the MSOP effect on ACPT-1 protection is abolished at higher doses. In contrast, the anticonvulsant protection against sound-induced seizures in DBA/2 mice provided by a fully protective dose (20 nmol, i.c.v.) of the mGlu(8) receptor agonist PPG, is not significantly affected by the co-administration of the same Group III antagonists, MSOP, MPPG or MAP4. We conclude that activation of either mGlu(4). or mGlu8 receptors confer anticonvulsant protection in DBA/2 mice. Furthermore, the metabotropic Group IH receptor antagonists, MSOP, MPPG, and MAN appear to be functionally selective for the mGlu4 receptor in this system. (C) 2001 Published by Elsevier Science B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据